By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pernix Therapeutics, Inc. 

P.O. Box 40

Gonzales  Louisiana  70707-0040  U.S.A.
Phone: 800-793-2145 Fax:



Company News
Pernix (PTX) Prevails In Zohydro ER ANDA Litigation 2/23/2017 10:43:47 AM
Pernix (PTX) Provides Update On Arbitration 2/3/2017 7:24:41 AM
Pernix (PTX) Appoints Ken PiƱa As General Counsel And Chief Compliance Officer 1/9/2017 7:26:56 AM
Pernix (PTX) Appoints New Board Member 11/22/2016 6:59:05 AM
Pernix (PTX) Reports Third Quarter 2016 Financial Results And Provides Business Update 11/11/2016 11:09:46 AM
Pernix (PTX) Appoints Two Board Members 11/8/2016 8:00:45 AM
Pernix (PTX) To Report Third Quarter 2016 Financial Results On November 10, 2016 11/1/2016 11:09:45 AM
Pernix (PTX) Announces Reverse Stock Split And Corporate Governance Enhancements 10/13/2016 8:00:04 AM
Pernix (PTX) Announces Distribution Of TREXIMET 10/60 Mg (Sumatriptan 10mg And Naproxen Sodium 60 Mg) Dose For Use In Pediatric Patients 9/29/2016 11:50:23 AM
Marsha Stanton, Ph.D., RN, Pernix (PTX) Executive Director Of Medical And Government Affairs, Awarded Prestigious Pain Management Advocacy Award From The American Society For Pain Management Nursing 9/16/2016 8:00:24 AM